gonococci


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to gonococci: gonococcus, meningococci

gon·o·coc·ci

(gon'ō-kok'sī), Avoid the mispronunciation gon-ō-kok'ī.
Plural of gonococcus.

gonococcus

[gon′əkok′əs] pl. gonococci
Etymology: Gk, gone + kokkos, berry
a gram-negative intracellular diplococcus of the species Neisseria gonorrhoeae, the cause of gonorrhea; a nonmotile aerobic microorganism of the species N. gonorrhoeae. It is a parasite of the mucous membrane.

gonococcus

(gon?o-kok'us) (gon?o-kok'si?) plural.gonococci [Gr. gonos, genitals, + kokkos, berry]
Neisseria gonorrhoeae, the gram-negative diplococcus that causes gonorrhea.
See: gonorrheagonococcal (gon?o-kok'al), adjectivegonococcic (gon?o-kok'sik)
References in periodicals archive ?
In principle, laboratory methods for susceptibility testing of gonococci are similar to those for other bacteria.
By 1944, however, many gonococci had become resistant to sulphanilamide and treatment failure was observed in over 30% of patients.
Moreover, our method could be a valuable molecular tool in an effective antimicrobial strategy to control gonococci.
This limitation is particularly relevant for the PorB-PCR PIA target, which as previously described, does not specifically target a mechanism of resistance, yet is highly associated with penicillin susceptibility in local Australia gonococci (17).
Given the speed with which gonococci developed resistance to fluoroquinolones, the CDC sees as inevitable the eventual development of resistance to cephalosporins--the currently favored agents for gonorrhea.
2, a level that has been proven in early clinical testing to render sperm immobile and inactivate most STI-causing organisms, including gonococci, herpes, Chlamydia, HPV and HIV.
For further examination of cross-immunity of MenB vaccines with gonococci, vaccine effectiveness studies in regions where OMV vaccine was used (e.
Gonorrhoea is one of the most common sexually transmitted disease caused by Neisseria gonococci.
The continued increase in antibioticresistant gonococci is the driving force behind 3 new gonorrhea treatment recommendations: (1) injectible ceftriaxone should be used rather than oral cefixime; (2) the ceftriaxone dose should be doubled from 125 to 250 mg; and (3) 1 g oral azithromycin should be administered (in addition to ceftriaxone), whether or not a chlamydial infection has been ruled out.
For example, rapid results of throat cultures for group A streptococci or of genital cultures for gonococci and Chlamydia trachomatis in outpatients can guide an early therapeutic decision.
Preclinical testing has also shown it to inactivate several STI-causing organisms, including gonococci, herpes, chlamydia and HIV.
These efforts should be used in public health responses to mitigate emergence and spread of ESC-resistant gonococci.